Feasibility and efficacy of a novel size adjustable cryoballoon for ablation of atrial fibrillation

J Interv Card Electrophysiol. 2024 Mar;67(2):253-255. doi: 10.1007/s10840-023-01645-2. Epub 2023 Sep 16.

Abstract

The aim of the present case series was to characterize the feasibility of a novel size adjustable cryoballoon system (PolarX Fit, Boston Scientific, Marlborough, MA, USA). This cryoballoon catheter can be inflated to two different diameters (28 mm and 31 mm) within the same procedure allowing vein adapted PVI. In summary, the novel size adjustable cryoballoon shows similar characteristics as the established versions. The intraprocedural flexibility of balloon size led to employment of the larger variant in the majority of freeze applications. Of note, in all but one procedure, both sizes were employed to ensure optimal occlusion for all veins. This initial series suggests that the size adjustable balloon offers more flexibility of obtain optimal occlusions in particular, in challenging anatomies, including common pulmonary vein ostia.

Keywords: Atrial fibrillation; Cryoballoon; Pulmonary vein isolation.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Atrial Fibrillation* / diagnostic imaging
  • Atrial Fibrillation* / surgery
  • Catheter Ablation* / methods
  • Catheters
  • Cryosurgery* / methods
  • Feasibility Studies
  • Humans
  • Pulmonary Veins* / surgery
  • Recurrence
  • Treatment Outcome